# Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET

> **NCT04992156** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 50 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Palbociclib

## Key facts

- **NCT ID:** NCT04992156
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-15
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-04-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04992156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04992156, "Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04992156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*